Biomarker Assessment

DIAGNOSTIC_TEST2 trials

Sponsors

CirQuest Labs, LLC, University Hospital, Strasbourg, France

Conditions

Coronary Artery DiseaseHeart Failure With Reduced Ejection FractionMultiple SclerosisMultiple Sclerosis (MS) - Relapsing-remittingRRMS

Unknown Phase

Assessment of Biomarkers in Patients With Decompensated Heart Failure and Underlying Coronary Artery Disease

CirQuest Labs, LLCCoronary Artery Disease, Heart Failure With Reduced Ejection Fraction

Start: 2018-07-10End: 2020-07-31Target: 120Updated: 2020-01-23

Multicenter Prospective Study Analyzing the Occurrence of Multiple Sclerosis Relapses Without Radiological Evidence: Myth or Reality?

Not yet recruitingNCT07545889

University Hospital, Strasbourg, FranceMultiple Sclerosis, Multiple Sclerosis (MS) - Relapsing-remitting, RRMS

Start: 2026-09-01End: 2030-05-01Target: 136Updated: 2026-04-22

Related Papers

Abstract 14206: Cross-Sectional, Exploratory Assessment of Biomarkers in Patients With Decompensated Heart Failure and Underlying Coronary Artery Disease (abide-hf)

Circulation2022-11-08